179 related articles for article (PubMed ID: 12135500)
1. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
2. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
3. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H
Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506
[TBL] [Abstract][Full Text] [Related]
4. BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation.
Chen Y; Wang C; Wu J; Li L
Biochem Biophys Res Commun; 2015 Jul; 462(3):208-14. PubMed ID: 25951976
[TBL] [Abstract][Full Text] [Related]
5. In search of a function for the TIS21/PC3/BTG1/TOB family.
Matsuda S; Rouault J; Magaud J; Berthet C
FEBS Lett; 2001 May; 497(2-3):67-72. PubMed ID: 11377414
[TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
7. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement.
Hata K; Nishijima K; Mizuguchi J
Exp Cell Res; 2007 Jul; 313(11):2356-66. PubMed ID: 17466295
[TBL] [Abstract][Full Text] [Related]
8. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
9. Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases.
Ikematsu N; Yoshida Y; Kawamura-Tsuzuku J; Ohsugi M; Onda M; Hirai M; Fujimoto J; Yamamoto T
Oncogene; 1999 Dec; 18(52):7432-41. PubMed ID: 10602502
[TBL] [Abstract][Full Text] [Related]
10. The mammalian anti-proliferative BTG/Tob protein family.
Winkler GS
J Cell Physiol; 2010 Jan; 222(1):66-72. PubMed ID: 19746446
[TBL] [Abstract][Full Text] [Related]
11. Expression of TOB/BTG family members in patients with inflammatory bowel disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Priego-Ranero ÁA; Martínez-Benítez B; Barreto-Zúñiga R; Yamamoto-Furusho JK
Scand J Immunol; 2021 Apr; 93(4):e13004. PubMed ID: 33247598
[TBL] [Abstract][Full Text] [Related]
12. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.
Micheli L; Ceccarelli M; Farioli-Vecchioli S; Tirone F
J Cell Physiol; 2015 Dec; 230(12):2881-90. PubMed ID: 25967096
[TBL] [Abstract][Full Text] [Related]
13. The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation.
Prévôt D; Voeltzel T; Birot AM; Morel AP; Rostan MC; Magaud JP; Corbo L
J Biol Chem; 2000 Jan; 275(1):147-53. PubMed ID: 10617598
[TBL] [Abstract][Full Text] [Related]
14. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation.
Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F
RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423
[TBL] [Abstract][Full Text] [Related]
15. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
16. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability.
Nakagawa K; Yokosawa H
Eur J Biochem; 2000 Mar; 267(6):1680-6. PubMed ID: 10712599
[TBL] [Abstract][Full Text] [Related]
17. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity.
Matsuda S; Kawamura-Tsuzuku J; Ohsugi M; Yoshida M; Emi M; Nakamura Y; Onda M; Yoshida Y; Nishiyama A; Yamamoto T
Oncogene; 1996 Feb; 12(4):705-13. PubMed ID: 8632892
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization of Tob is important for regulation of its antiproliferative activity.
Kawamura-Tsuzuku J; Suzuki T; Yoshida Y; Yamamoto T
Oncogene; 2004 Aug; 23(39):6630-8. PubMed ID: 15235587
[TBL] [Abstract][Full Text] [Related]
19. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
20. ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system.
Yoshida Y; Matsuda S; Ikematsu N; Kawamura-Tsuzuku J; Inazawa J; Umemori H; Yamamoto T
Oncogene; 1998 May; 16(20):2687-93. PubMed ID: 9632145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
